Dr Bradley John Seaman, MD | |
2330 E Meyer Blvd Ste 104, Kansas City, MO 64132-1132 | |
(816) 478-4200 | |
Not Available |
Full Name | Dr Bradley John Seaman |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 16 Years |
Location | 2330 E Meyer Blvd Ste 104, Kansas City, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437310307 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Doctors Hospital Llc | Leawood, KS | Hospital |
Menorah Medical Center | Overland park, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ascentist Physicians Group Llc | 9335143759 | 107 |
Ascentist Physicians Group Llc | 9335143759 | 107 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer.
"Erratic weather has exacerbated food insecurity in one of Indonesia's driest regions," including the districts of West Timor (TTS), Nusa Tengarra Timor (NTT), and North Central Timor (TTU), "leaving farmers and families hoping for the best as October's planting season approaches," IRIN reports.
4SC AG a drug discovery and development company focused on autoimmune and cancer indications, today announced the first treatment in a Phase I study evaluating 4SC-205, an oral Eg5 kinesin spindle protein inhibitor, in patients with solid tumours or malignant lymphomas.
› Verified 1 days ago
Entity Name | Ascentist Physicians Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060829000434 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer.
"Erratic weather has exacerbated food insecurity in one of Indonesia's driest regions," including the districts of West Timor (TTS), Nusa Tengarra Timor (NTT), and North Central Timor (TTU), "leaving farmers and families hoping for the best as October's planting season approaches," IRIN reports.
4SC AG a drug discovery and development company focused on autoimmune and cancer indications, today announced the first treatment in a Phase I study evaluating 4SC-205, an oral Eg5 kinesin spindle protein inhibitor, in patients with solid tumours or malignant lymphomas.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Bradley John Seaman, MD 2330 E Meyer Blvd Ste 104, Kansas City, MO 64132-1132 Ph: (816) 478-4200 | Dr Bradley John Seaman, MD 2330 E Meyer Blvd Ste 104, Kansas City, MO 64132-1132 Ph: (816) 478-4200 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer.
"Erratic weather has exacerbated food insecurity in one of Indonesia's driest regions," including the districts of West Timor (TTS), Nusa Tengarra Timor (NTT), and North Central Timor (TTU), "leaving farmers and families hoping for the best as October's planting season approaches," IRIN reports.
4SC AG a drug discovery and development company focused on autoimmune and cancer indications, today announced the first treatment in a Phase I study evaluating 4SC-205, an oral Eg5 kinesin spindle protein inhibitor, in patients with solid tumours or malignant lymphomas.
› Verified 1 days ago
Dr. Kim Ann Suk Baker, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3042 | |
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |